Watch Ticker

Verrica Pharmaceuticals Inc. Common Stock

Go to Verrica Pharmaceuticals Inc. Common Stock Website

$5.58

0.01 (0.18%)

Live

Previous Close

$5.57

Day Range

$5.5526 - $5.8099

Previous Day Range

$5.49 - $5.8425

Market Cap

$52.2 million USD

Day Vol.

8063

Previous Day Vol.

13576

Currency

USD

Primary Exchange

Nasdaq

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference

Verrica Pharmaceuticals announced the acceptance of two abstracts featuring positive preliminary results from a Phase 2 study of its investigational therapy VP-315 for the treatment of basal cell carcinoma. The data showed promising safety, tolerability, and antitumor efficacy.

Related tickers: VRCA.

Read Full Article

N/A - Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

Verrica Pharmaceuticals reported Q2 2024 financial results, including $4.9M in YCANTH revenue and positive preliminary results from a Phase 2 study of VP-315 for basal cell carcinoma. The company also announced progress in its common warts program and expansion of YCANTH distribution.

Related tickers: VRCA.

Read Full Article

Trending Tickers

Please sign in to view